Categories AlphaGraphs, Earnings, Health Care
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
Fourth-quarter revenues declined 5% annually to $10.89 billion, mainly reflecting weak performance by the Laboratory Products and Life Sciences Solutions segments.
Adjusted earnings, meanwhile, moved up to $5.67 per share in the December quarter from $5.40 per share a year earlier. The reported profit was $1.63 billion or $4.20 per share, compared to $1.58 billion or $4.01 per share in the prior-year quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
